Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Casopis Lekaru Ceskych
|
April 6, 2005
[Organ changes induced by ergot derivative dopamine agonist drugs: time to change treatment guidelines in Parkinson's disease?]
J Roth, O Ulmanová, E Růzicka
Casopis Lekaru Ceskych
|
April 10, 1992
[Botulinum toxin in the treatment of blepharospasm. Initial experience]
E Růzicka, J Roth, P Diblík
Casopis Lekaru Ceskych
|
August 23, 2000
[Effect of normalization of an isolated increase in TSH on the neuropsychological profile of patients]
J Jensovský, N Spacková, B Hejduková, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 6, 2000
Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson's disease
E Růzicka, J Roth, R Jech, et al.
Ceskoslovenska Gynekologie
|
September 1, 1988
[The level of knowledge about sex in minor girls seeking abortion]
J Raboch, Z Dytrych, E Růzicka, et al.
Ceskoslovenska Epidemiologie, Mikrobiologie, Imunologie
|
October 1, 1987
[Directed immunization of female employees in the health services and schools using live rubella vaccine strain RA 27/3 on the basis of a screening test with radial hemolysis]
J Strauss, M Mrázová, I Macátová, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 1, 1994
Apomorphine induced cognitive changes in Parkinson's disease
E Růzicka, J Roth, N Spacková, et al.
Functional Neurology
|
June 17, 1998
Apomorphine does not influence olfactory thresholds in Parkinson's disease
J Roth, T Radil, E Růzicka, et al.
Journal of Neurology
|
August 1, 1997
Spatial and nonspatial memory involvement in myasthenia gravis
V D Bohbot, R Jech, J Bures, et al.
Sbornik Lekarsky
|
February 28, 2001
The effects of apomorphine on attentional processing in Parkinson's disease
E Růzicka, F el Massioui, B Pillon, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Casopis Lekaru Ceskych
|
April 6, 2005
[Organ changes induced by ergot derivative dopamine agonist drugs: time to change treatment guidelines in Parkinson's disease?]
J Roth, O Ulmanová, E Růzicka
Casopis Lekaru Ceskych
|
April 10, 1992
[Botulinum toxin in the treatment of blepharospasm. Initial experience]
E Růzicka, J Roth, P Diblík
Casopis Lekaru Ceskych
|
August 23, 2000
[Effect of normalization of an isolated increase in TSH on the neuropsychological profile of patients]
J Jensovský, N Spacková, B Hejduková, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 6, 2000
Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson's disease
E Růzicka, J Roth, R Jech, et al.
Ceskoslovenska Gynekologie
|
September 1, 1988
[The level of knowledge about sex in minor girls seeking abortion]
J Raboch, Z Dytrych, E Růzicka, et al.
Ceskoslovenska Epidemiologie, Mikrobiologie, Imunologie
|
October 1, 1987
[Directed immunization of female employees in the health services and schools using live rubella vaccine strain RA 27/3 on the basis of a screening test with radial hemolysis]
J Strauss, M Mrázová, I Macátová, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 1, 1994
Apomorphine induced cognitive changes in Parkinson's disease
E Růzicka, J Roth, N Spacková, et al.
Functional Neurology
|
June 17, 1998
Apomorphine does not influence olfactory thresholds in Parkinson's disease
J Roth, T Radil, E Růzicka, et al.
Journal of Neurology
|
August 1, 1997
Spatial and nonspatial memory involvement in myasthenia gravis
V D Bohbot, R Jech, J Bures, et al.
Sbornik Lekarsky
|
February 28, 2001
The effects of apomorphine on attentional processing in Parkinson's disease
E Růzicka, F el Massioui, B Pillon, et al.
Page
of 3